Health Trials

Bloodstream Infection (BSI)

1

Review clinical trials related to Bloodstream Infection (BSI). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

The study will evaluate the efficacy and safety of Meropenem and Pralurbactam versus Best Available Therapy in the treatment of Carbapenem-Resistant Enterobacteriaceae Infections. Infections evaluated in the study will be hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), complicated intra-abdominal infection (cIAI), complicated urinary tract infection (cUTI), and Bloodstream Infection (BSI).

Participants needed: 80
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Qilu Pharmaceutical Co., Ltd.Updated: Jul 30, 2025Locations: 1
Eligibility criteria

Hospitalized male or female≥18 and ≤80 years of age， [+4]

Participants who need more than 3 systemic antibiotics as part of best available... [+4]

Read more